Ribonomics, Inc. is a functional genomics company employing a system of integrated technology platforms to discover novel therapeutic targets. The Ribonomic Technology Platform employs in vivo methods for discerning structural and functional relationships between genes and human disease. The company is focusing its initial research programs on cancer, metabolic diseases, and central nervous system disorders.
http://www.ribonomics.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.6 seconds
Shinobu Kitamura
Shinobu Kitamura
15A Con●●●●●●●ion Way
Wo●●rn , MA, 01801
US
View this contact
Shinobu Kitamura
Shinobu Kitamura
15A Con●●●●●●●ion Way
Wo●●rn , MA, 01801
US
View this contact
Shinobu Kitamura
Shinobu Kitamura
15A Con●●●●●●●ion Way
Wo●●rn , MA, 01801
US
View this contact
BUY YOUR DOMAIN
25
YEARS
10
MONTHS
16
DAYS
TUCOWS DOMAINS INC.
WHOIS : whois.tucows.com
REFERRED : http://domainhelp.opensrs.net
PAGES IN
THIS WEBSITE
3
SSL
EXTERNAL LINKS
0
SITE IP
216.27.21.94
LOAD TIME
0.609 sec
SCORE
6.2
Ribonomics: innovative functional genomics | ribonomics.com Reviews
https://ribonomics.com
Ribonomics, Inc. is a functional genomics company employing a system of integrated technology platforms to discover novel therapeutic targets. The Ribonomic Technology Platform employs in vivo methods for discerning structural and functional relationships between genes and human disease. The company is focusing its initial research programs on cancer, metabolic diseases, and central nervous system disorders.
ribonomics.com
Ribonomics: Company Profile
http://www.ribonomics.com/company/index.html
Ribonomics, Inc. is a Systems Biology company focused on the development of innovative products for the diagnosis and treatment of human diseases. Employing proprietary technologies developed at Duke University Medical Center, the Company empirically connects biological pathways to human disease. This capability represents a powerful solution for accelerating drug discovery. The core of the Ribonomics Technology Platform.
Ribonomics: Partners
http://www.ribonomics.com/partners/index.html
Ribonomics Inc. received its seed funding from a single corporate partner, Medical and Biological Laboratory, Co. Ltd., a publicly traded Japanese life science company that is the leading manufacturer of autoimmune diagnostics in Japan. MBL has several subsidiaries, in Japan and the United States, that extend across a wide range of life science applications. To learn more about MBL, please visit their website at www.mbl.co.jp.
Ribonomics: News
http://www.ribonomics.com/news/index.html
May 7, 2004. Ribonomics Receives $663,000 in Grants from the National Institutes of Health. February 3, 2004. Ribonomics Receives $150,000 from the North Carolina Biotechnology Center. October 22, 2003. Ribonomics, Inc. Announces U.S. Patent Issuance For Pathways Discovery Technologies. August 14, 2003. Ribonomics Receives a $420,000 Grant from the Department of Defense to Develop its Systems Biology Technology. July 15, 2003. September 16, 2002. April 15, 2001.
TOTAL PAGES IN THIS WEBSITE
3
ribonnokishi (caitlin) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 1 Year. This deviant's full pageview. This is the place where you can personalize your profile! You can drag and drop to rearrange.
Ares Lab Home
Ares Laboratory, UC Santa Cruz. Manuel Ares, Jr., Professor of Molecular, Cell and Developmental Biology. Our work centers on the mechanisms and regulation of splicing. Splicing is required to remove intron sequences from pre-mRNA and create coding sequences for translation. We try to understand:. 1) the mechanism of action of the core components of the spliceosome, in particular the snRNAs and their rearrangements during assembly of the spliceosome and catalysis of the splicing reactions,.
Main Page - Bio.pe
10,000 Korean Human Genome Project. Ancient East Asian Genomes. Korean page: genomekorea.kr. Retrieved from " http:/ www.ribonome.net/index.php/Main Page. Related Links [ Edit. This page was last modified on 26 January 2017, at 08:38. This page has been accessed 1,604,221 times. Content is available under BioLicense: the freest license.
Main Page - Bio.pe
10,000 Korean Human Genome Project. Ancient East Asian Genomes. Korean page: genomekorea.kr. Retrieved from " http:/ www.ribonome.org/index.php/Main Page. Related Links [ Edit. This page was last modified on 26 January 2017, at 08:38. This page has been accessed 1,604,222 times. Content is available under BioLicense: the freest license.
Main Page - Bio.pe
10,000 Korean Human Genome Project. Ancient East Asian Genomes. Korean page: genomekorea.kr. Retrieved from " http:/ www.ribonomics.net/index.php/Main Page. Related Links [ Edit. This page was last modified on 26 January 2017, at 08:38. This page has been accessed 1,604,222 times. Content is available under BioLicense: the freest license.
Main Page - Bio.pe
10,000 Korean Human Genome Project. Ancient East Asian Genomes. Korean page: genomekorea.kr. Retrieved from " http:/ www.ribonomics.org/index.php/Main Page. Related Links [ Edit. This page was last modified on 26 January 2017, at 08:38. This page has been accessed 1,604,224 times. Content is available under BioLicense: the freest license.
Ribonova
Is a biomedical research company in the. Lankenau Institute for Medical Research. Phone: 1 (610) 801-2541. Fax: 1 (610) 801-2542. Lankenau Institute for Medical Research R133. 100 East Lancaster Avenue. Wynnewood, PA 19096, USA. RiboNova is a registered trademark of RiboNova Inc.
プラセンタが終わる日
